Monopar Therapeutics (MNPR) Times Interest Earned (2017 - 2025)
Monopar Therapeutics (MNPR) reported Times Interest Earned of -$36.94 for Q3 2025, down 41.73% sequentially from -$26.06 in Q2 2025.
Monopar Therapeutics (MNPR) Times Interest Earned (2017 - 2025) Analysis & Trends
Monopar Therapeutics (MNPR) has 7 years of Times Interest Earned data on file, last reported at -$36.94 in Q3 2025.
- For the quarter ending Q3 2025, Times Interest Earned changed N/A year-over-year to -$36.94; the trailing twelve-month figure through Sep 2025 stood at -$109.42 (changed N/A YoY), and the FY2025 full-year result was $0.38, up 187.73% from the prior year.
- Times Interest Earned eased to -$36.94 in Q3 2025, from -$26.06 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.26 in Q4 2022 to a low of -$805454.2 in Q1 2025.
- A 3-year average of -$100847.0 and a median of -$34.77 in 2022 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned increased 19.81% in 2021 and advanced 24.82% in 2022, its largest moves.
- Tracing MNPR's Times Interest Earned over 3 years: stood at -$0.35 in 2021, then rose by 24.82% to -$0.26 in 2022, then sank by 14048.61% to -$36.94 in 2025.
- Business Quant data shows MNPR's Times Interest Earned at -$36.94 in Q3 2025, -$26.06 in Q2 2025, and -$805454.2 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Monopar Therapeutics | 800.03 Mn | 738.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -36.94 |
| Jun 30, 2025 | -26.06 |
| Mar 31, 2025 | -805,454.25 |
| Dec 31, 2022 | -0.26 |
| Sep 30, 2022 | -709.09 |
| Jun 30, 2022 | -32.60 |
| Mar 31, 2022 | -516.43 |
| Dec 31, 2021 | -0.35 |
| Dec 31, 2020 | -0.43 |
| Dec 31, 2019 | -0.48 |
| Sep 30, 2019 | -100.47 |
| Jun 30, 2019 | -61.66 |
| Mar 31, 2019 | -62.06 |
| Dec 31, 2018 | -0.55 |
| Sep 30, 2018 | -88.31 |
| Jun 30, 2018 | -44.16 |
| Mar 31, 2018 | -39.57 |
| Dec 31, 2017 | -0.74 |